Standout Papers
Citation Impact
Citing Papers
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Methicillin-Resistant Staphylococcus aureus and Its Relationship to Antimicrobial Use: Possible Implications for Control
1998
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
2000 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Disease Management Programs for Type 2 Diabetes in Germany
2014
Pathophysiology of Progressive Nephropathies
1998 Standout
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
2003
Dysregulation of Atrial Natriuretic Factor in Hypertension-Prone Man*
1990
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
1990 Standout
Health-financing reforms in southeast Asia: challenges in achieving universal coverage
2011
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
In Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic Mice
1988
Atopic dermatitis
2015 Standout
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
The metabolic syndrome
2010 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins
1995
Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition
2017 Standout
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Integrated Ambulatory Specialist Care — Germany's New Health Care Sector
2015
Antihypertensive therapy: Taking lipids into consideration
1991
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Diuretics and β-Blockers Do Not Have Adverse Effects at 1 Year on Plasma Lipid and Lipoprotein Profiles in Men With Hypertension
1999
The Science of Antibiotic Discovery
2020 Standout
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems
2005
Human resources for health in southeast Asia: shortages, distributional challenges, and international trade in health services
2011 Standout
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
The Art of Fusion: From Penams and Cephems to Penems
2003
Efficacy and tolerance of spironolactone in essential hypertension
1987
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
The post-antibiotic sub-MIC effect in vitro and in vivo
1993
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
2004
Global burden of blood-pressure-related disease, 2001
2008 Standout
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
1989
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Overcoming fragmentation in health care: chronic care in Austria, Germany and the Netherlands
2012
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
1988
Versatility of Aminoglycosides and Prospects for Their Future
2003
Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis
1991
The population dynamics of antimicrobial chemotherapy
1997
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
1995 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Effects of indapamide on the quality of life of hypertensive patients
1988
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design
1990
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Pharmacodynamics of Daptomycin in a Murine Thigh Model of Staphylococcus aureus Infection
2001
The Postantibiotic Effect in the Treatment of Experimental Meningitis Caused by Streptococcus pneumoniae in Rabbits
1984
Insulin Resistance in Essential Hypertension
1987 Standout
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Once-daily dosing regimen for aminoglycoside plus β-Lactam combination therapy of serious bacterial infections: Comparative trial with netilmicin plus ceftriaxone
1990
Racial Variation in Cardiac Procedure Use and Survival Following Acute Myocardial Infarction in the Department of Veterans Affairs
1994 Standout
First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use
1991
Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties
2016 Standout
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
1993
Therapeutic Efficacy of Continuous Versus Intermittent Administration of Ceftazidime in an Experimental Klebsiella pneumoniae Pneumonia in Rats
1985
Comparative Study of the Effect of ACE-Inhibitors and Other Antihypertensive Agents on Proteinuria in Diabetic Patients
1994
Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model
1991
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Postantibiotic effect of imipenem on Pseudomonas aeruginosa
1984
MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
1991 Standout
Machine Learning in Medicine
2019 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Kinetics of antimicrobial activity
1986
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
Blood pressure, stroke, and coronary heart disease
1990 Standout
Controlled clinical trials of drug treatment for hypertension. A review.
1989
The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure
1988
Methicillin-Resistant Staphylococcus aureus and Its Relationship to Antimicrobial Use: Possible Implications for Control
1998
Functional textiles for atopic dermatitis: a systematic review and meta‐analysis
2013
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance
1987
Global Burden of Cardiovascular Diseases
2001 Standout
Coronary Plaque Disruption
1995 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis
1993
A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.
1988
Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive Hypertension
1995 StandoutScienceNobel
COMPARISON OF WEIGHT REDUCTION WITH METOPROLOL IN TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS
1985
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Coronary artery disease in blacks: Risk factors
1984
Effects of propranolol on atherogenesis in the cholesterol-fed rabbit.
1985
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
1994
Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study
2017
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of Andreas Gerber being referenced
German Diabetes Management Programs Improve Quality Of Care And Curb Costs
2010
Use of Antimicrobials in Swiss Hospitals
1996
Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany
2008 Standout
Electronic medical record use in pediatric primary care
2010
Is prevention of atopic eczema with hydrolyzed formulas cost‐effective? A health economic evaluation from Germany
2012
Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.
1982
Effects of antihypertensive therapy on serum lipoproteins.
1983
Calcium antagonists in the treatment of hypertension: a critical overview.
1985
Antibiotic Therapy of Infections Due to Pseudomonas aeruginosa in Normal and Granulocytopenic Mice: Comparison of Murine and Human Pharmacokinetics
1986
Body Sodium/Blood Volume State in Normotensive Members of Normotensive and Hypertensive Families
1986
Serum lipoproteins during treatment with the antihypertensive agent indapamide.
1985
Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo
1984
Worldwide Clinical Experience with Cefoperazone
1981
Postantibiotic Suppression of Bacterial Growth
1981
Constant Infusions vs. Intermittent Doses of Gentamicin Against Pseudomonas aeruginosa in Vitro
1982
Antihypertensive Treatment and Serum Lipoproteins
1985
Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model
1991
Selection of Aminoglycoside-Resistant Variants of Pseudomonas aeruginosa in an in Vivo Model
1982
Growth kinetics of respiratory pathogens after short exposures to ampicillin and erythromycin in vitro
1981
Impact of Dosing Intervals on Activity of Gentamicin and Ticarcillin Against Pseudomonas aeruginosa in Granulocytopenic Mice
1983
Pharmacokinetics of Cefoperazone in Patients with Normal and Impaired Hepatic and Renal Function
1983